beta-alanine has been researched along with Diabetes Mellitus, Adult-Onset in 19 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dabigatran is a direct thrombin inhibitor indicated for stroke and systemic embolism prevention in patients with non-valvular atrial fibrillation." | 3.80 | [Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery]. ( Bachellerie, B; Conil, JM; Crognier, L; Fourcade, O; Georges, B; Ruiz, S; Seguin, T, 2014) |
| "To conduct a dose-response assessment of the efficacy and safety of the glucagon receptor antagonist PF-06291874 in adults with type 2 diabetes (T2DM) using stable doses of metformin." | 2.87 | Efficacy and safety of the glucagon receptor antagonist PF-06291874: A 12-week, randomized, dose-response study in patients with type 2 diabetes mellitus on background metformin therapy. ( Bergman, AJ; Calle, RA; Chidsey, K; Kazierad, DJ; Somayaji, VR, 2018) |
| " In an acute dog glucagon challenge test, compound 13K significantly inhibited glucagon-mediated blood glucose increase when dosed orally at 10 mg/kg." | 1.51 | Discovery of potent and orally bioavailable indazole-based glucagon receptor antagonists for the treatment of type 2 diabetes. ( Demarest, K; DesJarlais, RL; DiLoreto, K; Du, F; Eckardt, A; Gaul, MD; Liang, Y; Rentzeperis, D; Santulli, R; Shook, B; Song, F; Xu, G, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 13 (68.42) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Sugimoto, T | 3 |
| Kamei, Y | 3 |
| Matthews, JJ | 3 |
| Turner, MD | 3 |
| Santos, L | 3 |
| Elliott-Sale, KJ | 3 |
| Sale, C | 3 |
| Xu, G | 1 |
| Gaul, MD | 1 |
| Song, F | 1 |
| Du, F | 1 |
| Liang, Y | 1 |
| DesJarlais, RL | 1 |
| DiLoreto, K | 1 |
| Shook, B | 1 |
| Rentzeperis, D | 1 |
| Santulli, R | 1 |
| Eckardt, A | 1 |
| Demarest, K | 1 |
| Dolan, E | 2 |
| Swinton, PA | 2 |
| Artioli, GG | 2 |
| Sa, Z | 1 |
| Zhou, J | 1 |
| Zou, Y | 1 |
| Su, Z | 1 |
| Gu, X | 1 |
| Savolainen, O | 1 |
| Lind, MV | 1 |
| Bergström, G | 1 |
| Fagerberg, B | 1 |
| Sandberg, AS | 1 |
| Ross, A | 1 |
| Kazierad, DJ | 2 |
| Chidsey, K | 1 |
| Somayaji, VR | 1 |
| Bergman, AJ | 1 |
| Calle, RA | 1 |
| Li, J | 1 |
| Qiu, P | 1 |
| Wang, S | 1 |
| Wu, J | 1 |
| He, Q | 1 |
| Li, K | 1 |
| Xu, L | 1 |
| Ribés-Cruz, JJ | 1 |
| Torregrosa-Maicas, I | 1 |
| Ramos-Tomás, C | 1 |
| Solís-Salguero, MA | 1 |
| Puchades-Montesa, MJ | 1 |
| González-Rico, MA | 1 |
| Juan-García, I | 1 |
| Tomás-Simó, P | 1 |
| Tejedor-Alonso, S | 1 |
| Zambrano-Esteves, P | 1 |
| Miguel-Carrasco, A | 1 |
| Bachellerie, B | 1 |
| Ruiz, S | 1 |
| Conil, JM | 1 |
| Crognier, L | 1 |
| Seguin, T | 1 |
| Georges, B | 1 |
| Fourcade, O | 1 |
| Grover, S | 1 |
| Dhanjal, JK | 1 |
| Goyal, S | 1 |
| Grover, A | 1 |
| Sundar, D | 1 |
| Guan, HP | 1 |
| Yang, X | 2 |
| Lu, K | 1 |
| Wang, SP | 1 |
| Castro-Perez, JM | 1 |
| Previs, S | 1 |
| Wright, M | 1 |
| Shah, V | 1 |
| Herath, K | 1 |
| Xie, D | 1 |
| Szeto, D | 1 |
| Forrest, G | 1 |
| Xiao, JC | 1 |
| Palyha, O | 1 |
| Sun, LP | 1 |
| Andryuk, PJ | 1 |
| Engel, SS | 1 |
| Xiong, Y | 2 |
| Lin, S | 1 |
| Kelley, DE | 1 |
| Erion, MD | 1 |
| Davis, HR | 1 |
| Wang, L | 1 |
| Bergman, A | 1 |
| Tan, B | 1 |
| Erion, DM | 1 |
| Somayaji, V | 1 |
| Lee, DS | 1 |
| Rolph, T | 1 |
| Pelantová, H | 1 |
| Bugáňová, M | 1 |
| Holubová, M | 1 |
| Šedivá, B | 1 |
| Zemenová, J | 1 |
| Sýkora, D | 1 |
| Kaválková, P | 1 |
| Haluzík, M | 1 |
| Železná, B | 1 |
| Maletínská, L | 1 |
| Kuneš, J | 1 |
| Kuzma, M | 1 |
| Guo, J | 1 |
| Candelore, MR | 1 |
| Liang, R | 1 |
| Miller, C | 1 |
| Dallas-Yang, Q | 1 |
| Jiang, G | 1 |
| McCann, PE | 1 |
| Qureshi, SA | 1 |
| Tong, X | 1 |
| Xu, SS | 1 |
| Shang, J | 1 |
| Vincent, SH | 1 |
| Tota, LM | 1 |
| Wright, MJ | 1 |
| Zhang, BB | 1 |
| Tata, JR | 1 |
| Parmee, ER | 1 |
| de Gea-García, JH | 1 |
| Alvarez, M | 1 |
| Ruiz-Villa, G | 1 |
| Jiménez-Parra, JD | 1 |
| Kobayashi, Y | 1 |
| Yasuba, H | 1 |
| Yamashita, K | 1 |
| Kita, H | 1 |
| Chiba, W | 1 |
| Hitomi, S | 1 |
| Lau, J | 1 |
| Behrens, C | 1 |
| Sidelmann, UG | 1 |
| Knudsen, LB | 1 |
| Lundt, B | 1 |
| Sams, C | 1 |
| Ynddal, L | 1 |
| Brand, CL | 1 |
| Pridal, L | 1 |
| Ling, A | 1 |
| Kiel, D | 1 |
| Plewe, M | 1 |
| Shi, S | 1 |
| Madsen, P | 1 |
2 reviews available for beta-alanine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Regulation of Skeletal Muscle Function by Amino Acids, Especially Non-Proteinogenic Amino Acids.
Topics: Aged; Amino Acids; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Humans; Leucine; Mammals; Mice; | 2022 |
Regulation of Skeletal Muscle Function by Amino Acids, Especially Non-Proteinogenic Amino Acids.
Topics: Aged; Amino Acids; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Humans; Leucine; Mammals; Mice; | 2022 |
Regulation of Skeletal Muscle Function by Amino Acids, Especially Non-Proteinogenic Amino Acids.
Topics: Aged; Amino Acids; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Humans; Leucine; Mammals; Mice; | 2022 |
Regulation of Skeletal Muscle Function by Amino Acids, Especially Non-Proteinogenic Amino Acids.
Topics: Aged; Amino Acids; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Humans; Leucine; Mammals; Mice; | 2022 |
Regulation of Skeletal Muscle Function by Amino Acids, Especially Non-Proteinogenic Amino Acids.
Topics: Aged; Amino Acids; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Humans; Leucine; Mammals; Mice; | 2022 |
Regulation of Skeletal Muscle Function by Amino Acids, Especially Non-Proteinogenic Amino Acids.
Topics: Aged; Amino Acids; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Humans; Leucine; Mammals; Mice; | 2022 |
Regulation of Skeletal Muscle Function by Amino Acids, Especially Non-Proteinogenic Amino Acids.
Topics: Aged; Amino Acids; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Humans; Leucine; Mammals; Mice; | 2022 |
Regulation of Skeletal Muscle Function by Amino Acids, Especially Non-Proteinogenic Amino Acids.
Topics: Aged; Amino Acids; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Humans; Leucine; Mammals; Mice; | 2022 |
Regulation of Skeletal Muscle Function by Amino Acids, Especially Non-Proteinogenic Amino Acids.
Topics: Aged; Amino Acids; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Humans; Leucine; Mammals; Mice; | 2022 |
Effect of Carnosine or β-Alanine Supplementation on Markers of Glycemic Control and Insulin Resistance in Humans and Animals: A Systematic Review and Meta-analysis.
Topics: Animals; Bayes Theorem; beta-Alanine; Blood Glucose; Carnosine; Diabetes Mellitus, Type 2; Dietary S | 2021 |
2 trials available for beta-alanine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Efficacy and safety of the glucagon receptor antagonist PF-06291874: A 12-week, randomized, dose-response study in patients with type 2 diabetes mellitus on background metformin therapy.
Topics: Adolescent; Adult; Aged; beta-Alanine; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Dos | 2018 |
Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Alanine Transaminase; Amino Acids; Aspartate Aminotransferases; beta-Alanine; Blood Glu | 2016 |
15 other studies available for beta-alanine and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Carnosine increases insulin-stimulated glucose uptake and reduces methylglyoxal-modified proteins in type-2 diabetic human skeletal muscle cells.
Topics: beta-Alanine; Carnosine; Diabetes Mellitus, Type 2; Glucose; Humans; Insulin; Insulin Resistance; Ma | 2023 |
Discovery of potent and orally bioavailable indazole-based glucagon receptor antagonists for the treatment of type 2 diabetes.
Topics: Amino Acid Sequence; Animals; beta-Alanine; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitu | 2019 |
The effect of carnosine or β-alanine supplementation on markers of glycaemic control and insulin resistance in human and animal studies: a protocol for a systematic review and meta-analysis.
Topics: Bayes Theorem; beta-Alanine; Carnosine; Diabetes Mellitus, Type 2; Dietary Supplements; Glycemic Con | 2020 |
Paralog-divergent Features May Help Reduce Off-target Effects of Drugs: Hints from Glucagon Subfamily Analysis.
Topics: Amino Acid Sequence; Animals; beta-Alanine; Binding Sites; Diabetes Mellitus, Type 2; Glucagon-Like | 2017 |
Biomarkers of food intake and nutrient status are associated with glucose tolerance status and development of type 2 diabetes in older Swedish women.
Topics: alpha-Tocopherol; beta-Alanine; Biomarkers; Case-Control Studies; Cholesterol; Diabetes Mellitus, Ty | 2017 |
β-N-Oxalyl-L-α,β-diaminopropionic acid from Panax notoginseng plays a major role in the treatment of type 2 diabetic nephropathy.
Topics: Amino Acids, Diamino; Animals; beta-Alanine; Cell Line; Cell Proliferation; Diabetes Mellitus, Exper | 2019 |
Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease.
Topics: Aged, 80 and over; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Diabetes Mellitus, | 2013 |
[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery].
Topics: Acute Kidney Injury; Aged, 80 and over; Alzheimer Disease; Antithrombins; Atrial Fibrillation; Benzi | 2014 |
Computational identification of novel natural inhibitors of glucagon receptor for checking type II diabetes mellitus.
Topics: beta-Alanine; Blood Glucose; Computational Biology; Diabetes Mellitus, Type 2; Glucagon; High-Throug | 2014 |
Glucagon receptor antagonism induces increased cholesterol absorption.
Topics: Animals; beta-Alanine; Cholesterol; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Humans; | 2015 |
Urinary metabolomic profiling in mice with diet-induced obesity and type 2 diabetes mellitus after treatment with metformin, vildagliptin and their combination.
Topics: Adamantane; Animals; beta-Alanine; Diabetes Mellitus, Type 2; Diet; Glucose Tolerance Test; Hypoglyc | 2016 |
Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine (MK-0893) for the treatment of type II diabetes.
Topics: Animals; Area Under Curve; beta-Alanine; Blood Glucose; CHO Cells; Cricetinae; Cricetulus; Diabetes | 2012 |
[Wünderlich syndrome in patient anticoagulated with dabigatran].
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia | 2013 |
[A case of successful medical treatment for necrotizing fasciitis of the chest wall with diabetic nephropathy].
Topics: Anti-Bacterial Agents; beta-Alanine; Cilastatin; Cilastatin, Imipenem Drug Combination; Diabetes Mel | 2005 |
New beta-alanine derivatives are orally available glucagon receptor antagonists.
Topics: Administration, Oral; Animals; beta-Alanine; Biological Availability; Diabetes Mellitus, Experimenta | 2007 |